Activity of cefepime, cefotaxime, ceftazidime, and aztreonam against extended-spectrum-producing isolates of Klebsiella pneumoniae and Escherichia coli from Chilean hospitals
- 1 April 2001
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 40 (1-2) , 41-43
- https://doi.org/10.1016/s0732-8893(01)00248-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Comparison of the MICs of cefepime for extended-spectrum beta-lactamase-producing and non-extended-spectrum beta-lactamase-producing strains of Enterobacter cloacae.Journal of Antimicrobial Chemotherapy, 2000
- Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997–1998Journal of Antimicrobial Chemotherapy, 2000
- In Vitro Activity of Cefepime against Multidrug‐Resistant Gram‐Negative Bacilli, Viridans Group Streptococci and Streptococcus pneumoniae from a Cross‐Canada Surveillance StudyCanadian Journal of Infectious Diseases and Medical Microbiology, 1998
- Trends in β‐Lactam Resistance Among EnterobacteriaceaeClinical Infectious Diseases, 1998
- Important and Emerging β-Lactamase-mediated Resistances in Hospital-based Pathogens: The Amp C EnzymesDiagnostic Microbiology and Infectious Disease, 1998
- Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utilityClinical Microbiology & Infection, 1997
- Evolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam AntibioticsClinical Infectious Diseases, 1997
- CefepimeDrugs, 1994
- Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation CephalosporinsAnnals of Internal Medicine, 1993
- Extended Broad-Spectrum -Lactamases Conferring Transferable Resistance to Newer -Lactam Agents in Enterobacteriaceae: Hospital Prevalence and Susceptibility PatternsClinical Infectious Diseases, 1988